SCHEMBL14036873

SCHEMBL14036873

Cc1ccccc1C(=O)OC[C@@H]1O[C@H]2OC(C)(C)OC2C1(C)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 1/20 0.36
TSHR P16473 3/20 0.36
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRB3 P13945 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 2/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14010468 1.00 ALDH1A1 (0.43) ALDH1A1HPGDL3MBTL1MEN1KMT2A
SCHEMBL12151564 0.87 ALDH1A1 (0.42) ALDH1A1HPGDL3MBTL1TSHRTDP1
SCHEMBL13530756 0.87 ALDH1A1 (0.42) ALDH1A1HPGDL3MBTL1TSHRTDP1
SCHEMBL12154717 0.87 ALDH1A1 (0.42) ALDH1A1HPGDL3MBTL1TSHRTDP1
SCHEMBL16576319 0.84 ALDH1A1 (0.60) ALDH1A1HPGDKMT2ATSHRTDP1
SCHEMBL20557340 0.84 ALDH1A1 (0.60) ALDH1A1HPGDKMT2ATSHRTDP1
SCHEMBL21418918 0.84 ALDH1A1 (0.60) ALDH1A1HPGDKMT2ATSHRTDP1
SCHEMBL14010467 0.83 ALDH1A1 (0.48) ALDH1A1HPGDL3MBTL1MEN1KMT2A
SCHEMBL14036875 0.83 ALDH1A1 (0.48) ALDH1A1HPGDL3MBTL1MEN1KMT2A
SCHEMBL14010442 0.77 ALDH1A1 (0.43) ALDH1A1HPGDL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7452901-B2 Anti-cancer phosphonate analogs GILEAD SCIENCES, INC. (US) 2008-11-18 US disclosed